Gut hormones in microbiota-gut-brain cross-talk
This 2020 review explains the influential role of gut microbiota in the gut-brain axis, focusing on the regulation of physiological functions by the microbiota-related gut hormones. These gut hormones are signalling molecules released by enteroendocrine cells present all over the gastrointestinal tract, and can play a crucial part in maintaining health. The gut microbiota itself are essential in the modulation of several gut-brain axis-related diseases, ranging from gastrointestinal disorders to psychiatric diseases. Sun et al. (2020) encouraged future studies to utilize this microbiota-hormones-gut brain axis in the development of novel therapeutics for psychiatric and gastrointestinal disorders, such as obesity, anxiety, and depression. [NPID: microbiome, MGBA, gut-brain axis, gut microbiome, GI tract, psychiatric diseases, obesity, anxiety, depression]
Year: 2020
Reference: Sun, L. J., Li, J. N., & Nie, Y. Z. (2020). Gut hormones in microbiota-gut-brain cross-talk. Chinese medical journal, 133(7), 826–833. https://doi.org/10.1097/CM9.0000000000000706
Related Studies
This 2021 study discusses the antidepressant effect of ketamine and its effectiveness in treatment-resistant depression. Around 30% of depressive patients are said to be resistant to treatment, which implies that there are not enough effective treatments for depression. The gut microbiome is increasingly recognized as an influential factor in depression, seemingly acting through the gut-microbiota-brain […]
In this cross-sectional study by Hernández-Cacho et al. (2025), participants from the PREDIMED-Plus trial (n = 400) were investigated for a potential gut–brain axis connection between gut microbiota and depression. Depression was identified by either the use of antidepressants or elevated scores on the Beck Depression Inventory-II. Researchers analyzed gut microbiota using 16S rRNA sequencing […]